Location History:
- Brightwell-Cum-Sotwell, GB (2009)
- Encinitas, CA (US) (2014)
Company Filing History:
1 out of 50 
1 out of 3,446 
1 out of 122 
Years Active: 2009-2014
Title: The Innovative Contributions of Benjamin Neuman
Introduction
Benjamin Neuman is a prominent inventor based in Encinitas, California. He has made significant contributions to the field of virology through his innovative inventions. With a total of two patents to his name, Neuman's work focuses on developing methods and compounds to combat viral infections.
Latest Patents
Neuman's latest patents include an oligonucleotide compound and method for treating nidovirus infections. This invention discloses a method and oligonucleotide compound designed to inhibit the replication of nidoviruses in virus-infected animal cells. The compound features a nuclease-resistant backbone, is capable of uptake by infected cells, contains between 8-25 nucleotide bases, and has a sequence that disrupts base pairing between transcriptional regulatory sequences in the viral genome. In practice, infected cells are exposed to this compound in an effective amount to inhibit viral replication.
Another significant patent by Neuman is an antisense antiviral compound and method for treating arenavirus infections. This invention provides antisense antiviral compounds and methods for inhibiting the growth of viruses from the Arenaviridae family. The compounds are particularly useful in treating arenavirus infections in mammals. These antisense antiviral compounds are substantially uncharged morpholino oligonucleotides with a sequence of 12-40 subunits, including at least 12 subunits that target complementary regions associated with viral RNA sequences.
Career Highlights